Evidence map›Paper›PMID 35604133›Full record

ArticleMicrobiology spectrum2022

Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study.

Angsana Phuphuakrat, Ekawat Pasomsub, Sirawat Srichatrapimuk, Suppachok Kirdlarp, Ampa Suksatu, Chanya Srisaowakarn, Suwimon Manopwisedjaroen, Natali Ludowyke, Priyo Budi Purwono, Thongkoon Priengprom and 6 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06047067 (BIOAEROSOL SAMPLING DEVICE), which is not on this map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06047067 unknown statusnot on this mapstarted 2023, after this paper: background citation

BIOAEROSOL SAMPLING DEVICE (BSD) CLINICAL STUDY: Performance of Respiratory Pathogen Bioaerosol Sampling Device Compared to Matched Swab Sample With Molecular and Antigen Assays That Can Detect SARS-CoV-2 Phase II Validation

TypeobservationalSponsorCantor BioConnect, Inc.Ran2023 to 2024Enrolled330ConditionsCOVID-19
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Successful lung transplantation using an allograft from a COVID-19-recovered donor: a potential role for subgenomic RNA to guide organ utilization.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Angsana PhuphuakratDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Ekawat PasomsubDepartment of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Sirawat SrichatrapimukChakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol Universitygrid.10223.32, Samut Prakan, Thailand.
Suppachok KirdlarpChakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol Universitygrid.10223.32, Samut Prakan, Thailand.
Ampa SuksatuDepartment of Microbiology, Faculty of Science, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Chanya SrisaowakarnDepartment of Microbiology, Faculty of Science, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Suwimon ManopwisedjaroenDepartment of Microbiology, Faculty of Science, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Natali LudowykeDepartment of Microbiology, Faculty of Science, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Priyo Budi PurwonoDepartment of Microbiology, Faculty of Science, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Thongkoon PriengpromCenter of Research Excellence in Immunoregulation, Faculty of Medicine Siriraj Hospital, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Artit WongsaCenter of Research Excellence in Immunoregulation, Faculty of Medicine Siriraj Hospital, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Ammarin ThakkinstianDepartment of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Suradej HongengDepartment of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Kumthorn MalathumDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Arunee ThitithanyanontDepartment of Microbiology, Faculty of Science, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Boonrat TassaneetrithepCenter of Research Excellence in Immunoregulation, Faculty of Medicine Siriraj Hospital, Mahidol Universitygrid.10223.32, Bangkok, Thailand.ORCID 0000-0001-9617-3659
Mahidol University · THSiriraj Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Determination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity is important in guiding the infection control and differentiating between reinfection and persistent viral RNA. Although viral culture is the gold standard to determine viral infectivity, the method is not practical. We studied the kinetics of SARS-CoV-2 total RNAs and subgenomic RNAs (sgRNAs) and their potential role as surrogate markers of viral infectivity. The kinetics of SARS-CoV-2 sgRNAs compared to those of the culture and total RNA shedding in a prospective cohort of patients diagnosed with coronavirus disease 2019 (COVID-19) were investigated. A total of 260 nasopharyngeal swabs from 36 patients were collected every other day after entering the study until the day of viral total RNA clearance, as measured by reverse transcription PCR (RT-PCR). Time to cessation of viral shedding was in order from shortest to longest: by viral culture, sgRNA RT-PCR, and total RNA RT-PCR. The median time (interquartile range) to negativity of viral culture, subgenomic N transcript, and N gene were 7 (5 to 9), 11 (9 to 16), and 18 (13 to 21) days, respectively (

Indexed as

COVID-19SARS-CoV-2BiomarkersHumansProspective StudiesRNA, ViralBiomarkersRNA, ViralCOVID-19infectivitySARS-CoV-2subgenomic RNAviral shedding

Identifiers

PMID35604133
PMCPMC9241878
OpenAlexW4281286548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.